Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction
about
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trialsFatty fish, marine omega-3 fatty acids and incidence of heart failureLipotoxicity in the heart.The dietary quality of persons with heart failure in NHANES 1999-2006Effects of dietary omega-3 fatty acids on ventricular function in dogs with healed myocardial infarctions: in vivo and in vitro studiesUpdate on lipids and mitochondrial function: impact of dietary n-3 polyunsaturated fatty acidsLow dietary fish-oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats.Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload.Treatment with docosahexaenoic acid, but not eicosapentaenoic acid, delays Ca2+-induced mitochondria permeability transition in normal and hypertrophied myocardium.Improved mitochondrial function with diet-induced increase in either docosahexaenoic acid or arachidonic acid in membrane phospholipids.Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease.Docosahexaenoic acid supplementation does not improve Western diet-induced cardiomyopathy in rats.Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts.Dietary fatty acids alter left ventricular myocardial gene expression in Wistar rats.Exploratory analysis on the use of statins with or without n-3 PUFA and major events in patients discharged for acute myocardial infarction: an observational retrospective study.Dietary supplementation with docosahexaenoic acid, but not eicosapentaenoic acid, dramatically alters cardiac mitochondrial phospholipid fatty acid composition and prevents permeability transition.Dietary fish oil modestly attenuates the effect of age on diastolic function but has no effect on memory or brain inflammation in aged ratsCyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acidsThe cardioprotective effects of fish oil during pressure overload are blocked by high fat intake: role of cardiac phospholipid remodeling.The role of dietary fatty acids in predicting myocardial structure in fat-fed ratsDocosahexaenoic acid supplementation alters key properties of cardiac mitochondria and modestly attenuates development of left ventricular dysfunction in pressure overload-induced heart failureEffect of a high-protein diet on development of heart failure in response to pressure overload.Krill oil attenuates left ventricular dilatation after myocardial infarction in rats.Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health studyFish oil increases raft size and membrane order of B cells accompanied by differential effects on function.Fish oil decreases inflammation and reduces cardiac remodeling in rosiglitazone treated aging mice.Dietary fat and heart failure: moving from lipotoxicity to lipoprotection.Stressing the heart of the matter: re-thinking the mechanisms underlying therapeutic effects of n-3 polyunsaturated fatty acids.How Are n-3 LCPUFAs Antiarrhythmic? A Reassessment of n-3 LCPUFAs in Cardiac Disease.Dietary Supplementation with Olive Oil or Fish Oil and Vascular Effects of Concentrated Ambient Particulate Matter Exposure in Human Volunteers.Omega-3 fatty acid supplementation and cardiovascular disease.Marine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure but do not improve survival.Evaluation of docosahexaenoic acid in a dog model of hypertension induced left ventricular hypertrophy.Fish oil selectively improves heart function in a mouse model of lipid-induced cardiomyopathyDietary saturated fat and docosahexaenoic acid differentially effect cardiac mitochondrial phospholipid fatty acyl composition and Ca(2+) uptake, without altering permeability transition or left ventricular function.omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential.Aldehyde stress and up-regulation of Nrf2-mediated antioxidant systems accompany functional adaptations in cardiac mitochondria from mice fed n-3 polyunsaturated fatty acids.Dietary omega-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+-induced permeability transition.Myocardial infarction does not affect fatty-acid profiles in rats.Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association.
P2860
Q24650348-77551F2D-F2AB-41E3-99B1-56E5260AEFBDQ28395992-5DEE360C-189A-4551-B4CE-490D66ED4546Q33665107-87FB9F2D-F68F-4BC7-A362-86C995AAB484Q33723328-F433275F-94D6-4B6C-A211-E48554D1CC26Q33784422-FD881EBB-E901-4D61-8FB2-680A57EBF6FFQ33792723-E6C9341E-5369-4A16-A873-D5419D668256Q33902043-185F97FB-8652-47A7-AB93-9A775085FDE5Q33917163-6487EE4E-DFF0-41E7-9E99-68F8237B9840Q34214662-C4940D04-63A5-4E88-BAF7-74CD38D56BA7Q34222543-CD1F38C1-330E-409B-B4A5-685DAC4C72DFQ34418028-EEE671DD-2816-4866-843D-2C938508589BQ34540353-EB9B9E9F-5B93-44CD-A414-A69538FCF7E5Q34664054-2563C38C-6BF5-491B-B090-A7F9CE9FCDEBQ34696146-1D906A13-EED1-4E62-A765-8660124D838AQ34720816-DD4B881D-C24A-4D35-ACD0-307604C149D4Q34767042-6FAD137B-D28A-4C7D-91F0-181DFB98FD0BQ34783642-F1A50E34-3666-4B1F-BEBB-EAFD506D0DF4Q34800981-9196E485-4AE7-4037-8160-5C34AC9B9BABQ35012952-454EF538-CA6E-4887-9B81-2F290BB0D502Q35081224-3883B781-1336-4016-A361-4E99A6E87C56Q35191017-7485FF9B-B837-4985-9C3D-8BBC7DB64C3CQ35230297-15CFCC75-388E-442D-B6E3-6A95738D4367Q35761506-7086FB2D-3866-4957-A2F9-C3769DC910C1Q35827241-FBBF7CE5-69CD-44A8-A093-18F5845E9746Q35839665-64569969-506B-411E-972C-460C7EC6F191Q35889770-32F3171E-D8D5-421B-9FD8-8332CE097063Q35974413-CEA151D8-BCC6-4984-8C87-0C7076B515D6Q36082159-B3678B1D-3D54-4C47-BB5A-4C8A7F813AA2Q36199969-8871E1F7-850A-4D0A-B161-2922CEEE6311Q36239349-8BBB38CC-34A8-4C42-9B78-E820CAF57E32Q36387184-D179AF0C-0EEF-4AB3-A557-0281D553B1E8Q36528123-65AAB68A-5E0C-4716-8E40-602AB579D126Q36691953-A35A9C4A-A2B7-4B56-A923-A6D8D7B6F378Q36754545-7C650362-5DFF-4249-A748-0BF1D45B777FQ37319441-9DE4407F-D13C-4489-AFBA-01D174AD1329Q37341044-87C80F7A-73B1-46FA-B532-194F7AF63948Q37342993-5A1DE2CE-C422-40F5-870A-9F81F40935F7Q37441247-0B49EB42-44E0-4E05-80EE-18BA8E3AF637Q37456415-D4BC01C9-DDCE-4880-ABE7-C70D65286FD6Q37458369-5CF8EDC3-2676-49D9-8DFA-A1CDDB91B97E
P2860
Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Fish oil, but not flaxseed oil ...... ad-induced cardiac dysfunction
@en
Fish oil, but not flaxseed oil ...... d-induced cardiac dysfunction.
@nl
type
label
Fish oil, but not flaxseed oil ...... ad-induced cardiac dysfunction
@en
Fish oil, but not flaxseed oil ...... d-induced cardiac dysfunction.
@nl
prefLabel
Fish oil, but not flaxseed oil ...... ad-induced cardiac dysfunction
@en
Fish oil, but not flaxseed oil ...... d-induced cardiac dysfunction.
@nl
P2093
P2860
P356
P1476
Fish oil, but not flaxseed oil ...... ad-induced cardiac dysfunction
@en
P2093
Agnes M Azimzadeh
Anselm Tintinu
Brian R Barrows
David J Chess
Hani N Sabbah
Karen M O'Shea
Monika K Duda
Ramzi J Khairallah
Victor G Sharov
Wenhong Xu
P2860
P304
P356
10.1093/CVR/CVN310
P577
2008-11-17T00:00:00Z